Suppr超能文献

肿瘤引流淋巴结中储存的类 CD8 T 细胞干细胞维持了持续的抗肿瘤免疫反应。

A reservoir of stem-like CD8 T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response.

机构信息

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06519, USA.

Department of Neuroscience, Yale University School of Medicine, New Haven, CT, USA.

出版信息

Sci Immunol. 2021 Oct;6(64):eabg7836. doi: 10.1126/sciimmunol.abg7836. Epub 2021 Sep 2.

Abstract

“Stem-like” TCF1 CD8 T (T) cells are necessary for long-term maintenance of T cell responses and the efficacy of immunotherapy, but, as tumors contain signals that should drive T cell terminal differentiation, how these cells are maintained in tumors remains unclear. In this study, we found that a small number of TCF1 tumor-specific CD8 T cells were present in lung tumors throughout their development. Yet, most intratumoral T cells differentiated as tumors progressed, corresponding with an immunologic shift in the tumor microenvironment (TME) from “hot” (T cell inflamed) to “cold” (non–T cell inflamed). By contrast, most tumor-specific CD8 T cells in tumor-draining lymph nodes (dLNs) had functions and gene expression signatures similar to T from chronic lymphocytic choriomeningitis virus infection, and this population was stable over time despite the changes in the TME. dLN T cells were the developmental precursors of, and were clonally related to, their more differentiated intratumoral counterparts. Our data support the hypothesis that dLN T cells are the developmental precursors of the TCF1 T cells in tumors that are maintained by continuous migration. Last, CD8 T cells similar to T were also present in LNs from patients with lung adenocarcinoma, suggesting that a similar model may be relevant in human disease. Thus, we propose that the dLN T reservoir has a critical function in sustaining antitumor T cells during tumor development and in protecting them from the terminal differentiation that occurs in the TME.

摘要

“类干细胞” TCF1 CD8 T(T)细胞对于 T 细胞反应的长期维持和免疫疗法的疗效是必要的,但是,由于肿瘤中含有应该驱动 T 细胞终末分化的信号,这些细胞如何在肿瘤中维持仍然不清楚。在这项研究中,我们发现,在肺肿瘤的整个发展过程中,少量 TCF1 肿瘤特异性 CD8 T 细胞存在于肿瘤中。然而,随着肿瘤的进展,大多数肿瘤内 T 细胞分化,这与肿瘤微环境(TME)的免疫转变相对应,从“热”(T 细胞炎症)转变为“冷”(非 T 细胞炎症)。相比之下,肿瘤引流淋巴结(dLN)中大多数肿瘤特异性 CD8 T 细胞具有类似于慢性淋巴细胞脉络丛脑膜炎病毒感染的功能和基因表达特征,并且尽管 TME 发生变化,该群体仍保持稳定。dLN T 细胞是肿瘤中 TCF1 T 细胞的发育前体,并且与其更分化的肿瘤内对应物具有克隆相关性。我们的数据支持这样一种假设,即 dLN T 细胞是通过连续迁移维持的肿瘤中 TCF1 T 细胞的发育前体。最后,在患有肺腺癌的患者的淋巴结中也存在类似于 T 的 CD8 T 细胞,这表明类似的模型可能与人类疾病有关。因此,我们提出,dLN T 储备在肿瘤发展过程中维持抗肿瘤 T 细胞并保护它们免受 TME 中发生的终末分化方面具有关键作用。

相似文献

引用本文的文献

本文引用的文献

7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验